View All Reports Email Us

Companion Diagnostic Market Research Report- Global Forecast To 2023 Companion Diagnostic Market Research Report- Global Forecast To 2023

  • ID: MRFR/HC/2231-CRR
  • |
  • May, 2017
  • |
  • Region: Global
  • |
  • 107 pages
  • |
  • Cooked Research Reports

Companion Diagnostics market information, by Technology (PCR, in-situ hybridization, & immunohistochemistry), by application (cancer, infectious diseases, cardiovascular diseases, CNS diseases, and others), by end user (Pharma & biotech Companies, Clinical laboratories, CRO, and other) - Forecast to 2023


 


Companion Diagnostics market by Technology, 2016 (USD Million)


 


Market Synopsis of Companion diagnostics market:

Market Scenario:


Companion Diagnostics are the tests and tools that are used to determine the effect of drug molecule on the particular patients and also the potential patients who can be benefited by a specific treatment. The use of companion diagnostic treatments is an exciting field of medical development. The potential value of companion diagnostics for patients is safer treatment with improved outcomes. The focus of medicine has always been the wellbeing of the individual patient but with medicine becoming an increasing burden on taxpayers, reducing the cost of that quality care is now of prime importance. Companion diagnostics offer an innovative way to achieve a better quality of care at a reduced price. Globally the market for companion diagnostics is growing rapidly at the CAGR of about 6% - 6.5% from 2017 to 2023.



Key Finding



  • The companion diagnostics global market is expected to reach $12,647.5 million by 2023.

  • PCR based Companion diagnostics holds the largest share of about 50%-55% of the market.

  • Globally, Asia-Pacific the fastest growing region and expected to grow at the rate of 16% during the forecast period.



Segments:                                                                                                                                        

Companion diagnostics market has been segmented on the basis of technology which comprises of Polymerase Chain Reaction (PCR), In-situ hybridization, and immunohistochemistry. PCR accounted for the largest market share of the total market in 2016. On the basis of application, market is segmented into cancer, infectious diseases, cardiovascular diseases, CNS diseases, and others. Cancer segment accounted for the largest market share of the total market in 2016. On the basis of end user, market is segmented into pharma & biotech Companies, Clinical laboratories, CRO, and other. Pharma & Biotech companies dominated the global market with the largest market share of the total market in 2016.



Regional Analysis of Companion diagnostics Market:       


Globally America is the largest market for Companion diagnostics. In Americas, North America is the major contributor to the companion diagnostics market. Europe is the second-largest market after Americas. Furthermore, Asia-Pacific market is expected to be the fastest growing market for companion diagnostics due to continuous developments in developing countries like India and China, and increasing healthcare expenditure in these countries. On the other hand, Middle East & Africa are expected to have a limited but steady growth.



Key Players for Companion diagnostics Market:                                        


Some of the key players in this market are: Abbott Laboratories, Agilent Technologies, ARUP Laboratories, F. Hoffmann-La Roche AG., Myriad Genetics Inc, QIAGEN N.V., and Thermo Fisher Scientific Inc.      


Intended Audience



  • Companion Diagnostic tests developers & service providers

  • Pharmaceutical & Biotechnology Companies

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Independent Research Laboratories

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Academic Institutes and Universities



The report for
Companion diagnostics market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

1    Report Prologue    

2    Market Introduction    

2.1    Definition    

2.2    Scope of Study    

2.3    Research Objective    

2.4    Assumptions & Limitations    

2.4.1    Assumptions    

2.4.2    Limitations    

2.5    Market Structure    

3    Research Methodology    

3.1    Research Process    

3.2    Primary Research    

3.3    Secondary Research    

4    Market Dynamics    

4.1    Introduction    

4.2    Drivers    

4.2.1    High Cost of drug discovery and drug development    

4.2.2    Rising need for the assessment of the efficacy and safety of the drugs    

4.2.3    Desperate Need of the Specific Medication for the Chronic and Rare Diseases    

4.3    Restraints    

4.3.1    Inaccuracy of the Tests    

4.4    Opportunities    

4.4.1    Development of the Companion Diagnostic Tools for Rare Disorders    

5    Market Factor Analysis    

5.1    Porter’s Five Forces Model    

5.1.1    Bargaining Power of Suppliers    

5.1.2    Bargaining Power of Buyers    

5.1.3    Threat of New Entrants    

5.1.4    Threat of Substitutes    

5.1.5    Intensity of Rivalry    

6    Global Companion Diagnostics Market, By Technology    

6.1    Introduction    

6.2    Polymerase Chain Reaction (PCR)    

6.3    In-situ Hybridization    

6.4    Immunohistochemistry    

7    Global Companion Diagnostics Market, By Application    

7.1    Introduction    

7.2    Cancer    

7.3    Infectious Diseases    

7.4    Cardiovascular Diseases    

7.5    Central Nervous System Disorders    

8    Global Companion Diagnostics Market, By End User    

8.1    Introduction    

8.2    Pharma & Biotech Companies    

8.3    Clinical Laboratories    

8.4    Contract Research Organizations    

9    Global Companion Diagnostics Market, By Region    

9.1    Introduction    

9.2    America    

9.2.1    US    

9.2.2    Canada    

9.2.3    South America    

9.3    Europe    

9.3.1    Germany    

9.3.2    France    

9.3.3    U.K.    

9.3.4    Italy    

9.3.5    Spain    

9.3.6    Rest Of Western Europe    

9.3.8    Eastern Europe    

9.4    Asia-Pacific    

9.4.2    Japan    

9.4.3    China    

9.4.5    India    

9.4.6    Republic of Korea    

9.4.8    Rest of Asia-Pacific    

9.5    Middle East & Africa    

9.5.1    Middle East    

9.5.2    Africa    

10    Competitive Landscape    

10.1    Introduction    

10.2    Company Share Analysis    

11    Company Profile    

11.1    Abbott Laboratories    

11.1.1    Company Overview    

11.1.2    Product/Business Segment Overview    11.1.3    Financial Updates    

11.1.4    Key Developments    

11.1.5    SWOT Analysis    

11.2    Agilent Technologies    

11.2.1    Company Overview    

11.2.2    Product/Business Segment Overview    

11.2.3    Financial Overview    

11.2.4    Key Development    

11.2.5    SWOT Analysis    

11.3    ARUP Laboratories    

11.3.1    Company Overview    

11.3.2    Product/Business Segment Overview    

11.3.3    Financial Overview    

11.3.4    Key Development    

11.3.5    SWOT Analysis    

11.4    F. Hoffmann-La Roche AG    

11.4.1    Overview    

11.4.2    Product/Business Segment Overview    

11.4.3    Financial Updates    

11.4.4    Key Developments    

11.4.5    SWOT Analysis    

11.5    Myriad Genetics, Inc.    

11.5.1    Company Overview    

11.5.2    Product/Business Segment Overview    

11.5.3    Financial Overview    

11.5.4    Key Developments    

11.5.5    SWOT Analysis    

11.6    Qiagen N.V.    

11.6.1    Company Overview    

11.6.2    Product/Business Segment Overview    

11.6.3    Financial Overview    

11.6.4    Key Development    

11.6.5    SWOT Analysis    

11.7    Thermo Fisher Scientific Inc.    

11.7.1    Company Overview    

11.7.2    Product/Business Segment Overview    

11.7.3    Financials    

11.7.4    Key Developments    

11.7.5    SWOT Analysis   

List of Tables

TABLE 1    Global COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD Million)    

TABLE 2    Global PCR based Companion Diagnostics MARKET, by region, 2014-2023  (USD Million)    

TABLE 3    Global In-situ hybridization based companion diagnostics MARKET, by region, 2014-2023 (USD Million)    

TABLE 4    GLOBAL immunohistochemistry BASED COMPANION DIAGNOSTICS MARKET, BY REGION, 2014-2023 (USD MILLION)    

TABLE 5    GLOBAL COMPANION DIAGNOSTICS MARKET, BY Application, 2014-2023 (USD MILLION)    

TABLE 6    GLOBAL companion diagnostics MARKET for cancer, BY REGION, 2014-2023  (USD MILLION)    

TABLE 7    GLOBAl companion diagnostics MARKET for Infectious diseases, BY REGION,  2014-2023 (USD MILLION)    

TABLE 8    GLOBAl companion diagnostics MARKET for cardiovascular diseases, BY REGION, 2014-2023 (USD MILLION)    

TABLE 9    GLOBAl companion diagnostics MARKET for CNS Disorders, BY REGION, 2014-2023 (USD MILLION)    

TABLE 10    GLOBAL COMPANION DIAGNOSTICS MARKET, BY end user, 2014-2023 (USD MILLION)    

TABLE 11    GLOBAL Companion Diagnostics MARKET for Pharma & Biotech Companies, BY REGION, 2014-2023 (USD MILLION)    

TABLE 12    GLOBAL companion diagnostics MARKET for clinical laboratories, BY REGION,  2014-2023 (USD MILLION)    

TABLE 13    GLOBAL companion diagnostics MARKET for CROs, BY REGION, 2014-2023  (USD MILLION)    

TABLE 14    GLOBAL COMPANION DIAGNOSTICS MARKET, BY Region, 2014-2023 (USD MILLION)    

TABLE 15    america COMPANION DIAGNOSTICS MARKET, BY region, 2014-2023 (USD MILLION)    

TABLE 16    AMERICA COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 17    AMERICA COMPANION DIAGNOSTICS MARKET, BY Application, 2014-2023 (USD MILLION)    

TABLE 18    AMERICA COMPANION DIAGNOSTICS MARKET, BY End user, 2014-2023 (USD MILLION)    

TABLE 19    US COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 20    US COMPANION DIAGNOSTICS MARKET, BY Application, 2014-2023 (USD MILLION)    

TABLE 21    US COMPANION DIAGNOSTICS MARKET, BY End user, 2014-2023 (USD MILLION)        

TABLE 22    Canada COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 23    Canada COMPANION DIAGNOSTICS MARKET, BY Application, 2014-2023 (USD MILLION)    

TABLE 24    Canada COMPANION DIAGNOSTICS MARKET, BY End user, 2014-2023 (USD MILLION)    

TABLE 25    South America COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023  (USD MILLION)    

TABLE 26    South America COMPANION DIAGNOSTICS MARKET, BY Application, 2014-2023  (USD MILLION)    

TABLE 27    South America COMPANION DIAGNOSTICS MARKET, BY End user, 2014-2023  (USD MILLION)    TABLE 28    Europe COMPANION DIAGNOSTICS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)    

TABLE 29    Europe COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 30    Europe COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)    

TABLE 31    Europe COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 32    Germany COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 33    Germany COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)    

TABLE 34    Germany COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 35    France COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 36    France COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)    

TABLE 37    France COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 38    U.K. COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    TABLE 39    U.K. COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)    

TABLE 40    U.K. COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 41    Italy COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 42    Italy COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)    

TABLE 43    Italy COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 44    Spain COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 45    Spain COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)    

TABLE 46    Spain COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 47    Rest of western Europe COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 48    Rest of western Europe COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)    

TABLE 49    Rest of western Europe COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 50    Eastern Europe COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023  (USD MILLION)    

TABLE 51    Eastern Europe COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023  (USD MILLION)    

TABLE 52    Eastern Europe COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023  (USD MILLION)    

TABLE 53    Asia-Pacific COMPANION DIAGNOSTICS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)    

TABLE 54    Asia-Pacific COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023  (USD MILLION)    

TABLE 55    Asia-Pacific COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 56    Asia-Pacific COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 57    Japan COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 58    Japan COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)    

TABLE 59    Japan COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 60    China COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 61    China COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)    

TABLE 62    China COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 63    India COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 64    India COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)    

TABLE 65    India COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 66    Republic of Korea COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023  (USD MILLION)

TABLE 67    Republic of Korea COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023  (USD MILLION)

TABLE 68    Republic of Korea COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023  (USD MILLION)    

TABLE 69    Rest of Asia-Pacific COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023  (USD MILLION)

TABLE 70    Rest of Asia-Pacific COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023  (USD MILLION)

TABLE 71    Rest of Asia-Pacific COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023  (USD MILLION)    

TABLE 72    Middle East & Africa COMPANION DIAGNOSTICS MARKET, BY Region, 2014-2023 (USD MILLION)    

TABLE 73    Middle East & Africa COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 74    Middle East & Africa COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)    

TABLE 75    Middle East & Africa COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023  (USD MILLION)

TABLE 76    Middle East COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023  (USD MILLION)    

TABLE 77    Middle East COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023  (USD MILLION)

TABLE 78    Middle East COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 79    Africa COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD MILLION)    

TABLE 80    Africa COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)    

TABLE 81    Africa COMPANION DIAGNOSTICS MARKET, BY END USER, 2014-2023 (USD MILLION)    

TABLE 82    Abbott Laboratories: Key Developments    

TABLE 83    Agilent technologies: KEY DEVELOPMENT    

TABLE 84    F. Hoffmann-La Roche AG: Key development    

TABLE 85    Myriad Genetics Inc: Key Developments    

TABLE 86    Qiagen: Key Development    

TABLE 87    Thermo Fisher Scientific Inc.: Key Developments   

List of Figures

FIGURE 1    Global companion diagnostics MARKET SHARE, By Technology, 2016 (%)    

FIGURE 2    Global companion diagnostics MARKET SHARE, BY application, 2016 (%)    

FIGURE 3    Global companion diagnostics MARKET SHARE, BY end user, 2016 (%)    

FIGURE 4    Global companion diagnostics MARKET SHARE, BY region, 2016 (%)    

FIGURE 5    Market Structure of GLOBAL companion diagnostics MARKET    

FIGURE 6    Research Process of MRFR    

FIGURE 7    Drivers, Retraints & Opportunities    

FIGURE 8    Porters five forces model    

FIGURE 9    Global Companion diagnostics Market, By Technology, 2016 & 2023    

FIGURE 10    GLOBAL COMPANION DIAGNOSTICS MARKET, BY Application, 2016 & 2023 (USD MILLION)    

FIGURE 11    GLOBAL COMPANION DIAGNOSTICS MARKET, BY End user, 2016 & 2023 (USD MILLION)    

FIGURE 12    Global COMPANION DIAGNOSTICS MARKET share, By region, 2016 (%)    

FIGURE 13    America Companion diagnostics Market Share, By region, 2016 (%)    

FIGURE 14    Europe Companion diagnostics Market Share, By Country, 2016 (%)    

FIGURE 15    Asia-Pacific Companion diagnostics Market Share, By Country, 2016 (%)    

FIGURE 16    Middle East & Africa Companion diagnostics Market, BY Region, 2016 (%)    

FIGURE 17    Abbott Laboratories: recent Financials (USD million)    

FIGURE 18    Abbott Laboratories: Segmental Revenue, 2016 (%)    

FIGURE 19    Abbott Laboratories: Geographical revenue, 2016 (%)    

FIGURE 20    Abbott Laboratories: SWOT Analysis    

FIGURE 21    Agilent Technologies: RECENT FINANCIALs    

FIGURE 22    Agilent: operating segments, 2016 (%)    

FIGURE 23    AGILENT Technologies: GEographic Mix, 2016 (%)    

FIGURE 24    Agilent technologies: SWOT ANALYSIS    

FIGURE 25    F. Hoffmann-La Roche AG: Financial Revenue    

FIGURE 26    F. Hoffmann-La Roche AG: Segmental Revenue    

FIGURE 27    F. Hoffmann-La Roche AG: geogrpahical Revenue    

FIGURE 28    F. HOFFMANN-LA ROCHE AG: SWOT ANALYSIS    

FIGURE 29    Myriad Genetics Inc. Recent Financials    

FIGURE 30    Myriad Genetics Inc Business Revenue, 2016 (%)    FIGURE 31    Myriad Genetics Inc: swot analysis    

FIGURE 32    Qiagen N.V.: Recent financials    

FIGURE 33    Qiagen N.V.: Segment mix, 2016 (%)    

FIGURE 34    Qiagen N.V.: geographic Mix, 2016 (%)    

FIGURE 35    QIAGEN N.V.: SWOT ANALYSIS    

FIGURE 36    Thermo Fisher Scientific Inc. Recent Financials    104

FIGURE 37    Thermo Fisher Scientific Inc. Business Revenue    104

FIGURE 38    Thermo Fisher Scientific Inc.: geographical Revenue    105

FIGURE 39    Thermo Fisher Scientific: SWOT Analysis    106

captcha
Please enter code
captcha
Please enter code

Purchase this Market Research Report

Add To Cart

Market Research Videos

Related TAGS

Related Report

Related Categories

REPORT YOU MIGHT BE INTERESTED

Contact Us

Email Us at: salesteam@marketresearchfuture.com | Reach Us at: + (646) 845 9349 (US), +44 208 133 9349 (uk)